Regulations.gov document
Determination That NYMALIZE (nimodipine), Oral Solution, 3 Milligrams/Milliliter, Was Not…
Notice · FDA-2020-P-1549 · posted Feb 22, 2021
Key facts
| Document ID | FDA-2020-P-1549-0008 |
|---|---|
| Title | Determination That NYMALIZE (nimodipine), Oral Solution, 3 Milligrams/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness |
| Document type | Notice |
| Subtype | Determinations |
| Agency | FDA |
| Docket | FDA-2020-P-1549 |
| Posted | Feb 22, 2021 |
| Federal Register citation | 86 FR 9944 |
| FR document number | 2021-03083 |
| Comment period opens | Feb 22, 2021 |
| Effective date | Feb 17, 2021 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: